SCHEMBL21885733

SCHEMBL21885733

O=C1Cn2c(c(-c3ccccc3)c3ccccc32)-c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.40
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 3/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RCE1 Q9Y256 1/20 0.36
NTRK1 P04629 2/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK14 Q16539 1/20 0.34
GAA P10253 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
AGTR1 P30556 1/20 0.33
PADI4 Q9UM07 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29449354 0.81 KDM4E (0.48) PDE4AKMT2AKDM4EHSD17B10HPGD
SCHEMBL28935986 0.74 KMT2A (0.46) PDE4AKMT2AKDM4EHSD17B10MEN1
SCHEMBL791079 0.71 KDM4E (0.36) PDE4AKMT2AKDM4EHSD17B10HPGD
SCHEMBL142563 0.69 NTRK1 (0.48) KMT2AKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL21885150 0.69 GAA (0.42) KMT2AKDM4EHSD17B10HPGDMEN1
SCHEMBL6264953 0.65 L3MBTL1 (0.42) KMT2AKDM4EHSD17B10HPGDMEN1
SCHEMBL10730607 0.64 KMT2A (0.40) KMT2AKDM4EHSD17B10HPGDMEN1
SCHEMBL2490336 0.64 AGTR1 (0.53) KMT2AKDM4EHSD17B10HPGDMEN1
SCHEMBL12324910 0.63 KDM4E (0.41) KMT2AKDM4EHSD17B10HPGDMEN1
SCHEMBL24735865 0.63 IL1R1 (0.44) KMT2AKDM4EHSD17B10HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737355-B2 Organic electroluminescence device and amine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-22 US disclosed
US-11737355-B2 Organic electroluminescence device and amine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-22 US disclosed
US-20200106022-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-02 US disclosed
EP-3628673-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE Samsung Display Co., Ltd. (KR) 2020-04-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200106022-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE MAOA, PNMT, TPH1 PDE4A 2368/4885KMT2A 1236/4885KDM4E 1099/4885
US-11737355-B2 Organic electroluminescence device and amine compound for organic electroluminescence device MAOA, PNMT, TPH1 PDE4A 2368/4885KMT2A 1236/4885KDM4E 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.